November 13, 2025

TruBridge, Inc. (TBRG) Stock Analysis: Investor Outlook with an 11.88% Potential Upside

TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare information services sector, presents an intriguing opportunity for investors seeking exposure to a niche segment of..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 383% Upside Potential Beckons Investors

Arcturus Therapeutics Holdings Inc. (ARCT), a biotechnology firm at the forefront of mRNA-based therapies and vaccines, is currently capturing investor attention with an astonishing projected upside..

Quantum-Si Incorporated (QSI): Investor Outlook with an 87.5% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI) is capturing the attention of investors with its pioneering technologies in the healthcare sector. As a medical devices company based in the..

Aura Biosciences, Inc. (AURA) Investor Outlook: Exploring a 280% Potential Upside in Biotechnology

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing investor attention with its promising clinical-stage advancements in the biotechnology sector. Specializing in precision therapies for solid tumors, Aura’s..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a Potential 380% Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology company, is gaining significant attention from investors due to its promising product pipeline and potential for substantial stock..

UroGen Pharma Ltd. (URGN) Stock Analysis: Unveiling a Potential 40% Upside in the Biotech Sector

UroGen Pharma Ltd. (NASDAQ: URGN) stands at an intriguing crossroads for investors, particularly those focused on the biotechnology sector. With a market capitalization of $1.18 billion,..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Unpacking a Potential 251% Upside in the Biotech Sector

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company based in San Diego, California, has captured the attention of investors with its promising pipeline and significant..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Is There a 58% Upside Potential in This Biotech Innovator?

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a biopharmaceutical company making waves in the healthcare sector with its focus on developing cutting-edge treatments for gastrointestinal diseases. As..

aTyr Pharma, Inc. (ATYR) Stock Analysis: A Biotech Firm with a 444% Potential Upside

Investors with an eye on the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing opportunity, given the company’s potential for significant upside. With..

TotalEnergies SE (TTE) Stock Analysis: Navigating a 9.36% Upside Potential in a Dynamic Energy Sector

TotalEnergies SE (NYSE: TTE), a prominent player in the integrated oil and gas sector, offers a compelling investment opportunity amidst a rapidly evolving energy landscape. With..

Exxon Mobil Corporation (XOM) Stock Analysis: Exploring a Potential 7.72% Upside Amidst Dividend Strength

As one of the world’s largest publicly traded oil and gas companies, Exxon Mobil Corporation (NYSE: XOM) is a cornerstone of the energy sector, commanding a..

Olema Pharmaceuticals, Inc. (OLMA): Investor Outlook on a Promising Biotech with 202% Upside Potential

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is capturing attention in the biotechnology sector with its compelling focus on developing breakthrough therapies for women’s cancers. As a clinical-stage..

RYDER provides specialist engineering for subsea cables and pipelines

RYDER focuses on subsea cable and pipeline design where depth, route and burial precision determine long‑term performance...

NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 154.93% Potential Upside

Nano-X Imaging Ltd. (NNOX) is capturing investor attention with a remarkable potential upside of 154.93%, according to recent analyst ratings. The Israel-based healthcare company, focused on..

Mereo BioPharma Group plc (MREO): Investor Outlook with a 284% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) is making waves in the biotechnology sector with its promising therapeutic developments targeting oncology and rare diseases. Based in the..

Chevron Corporation (CVX) Stock Analysis: Navigating a 12.24% Potential Upside in the Energy Sector

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, commands significant attention from investors with its substantial market capitalization of $306.54 billion. Positioned within the..

Graphite remains essential as industry shifts

Graphite demand is rising steadily as it remains critical for batteries, steelmaking, and thermal systems...

TEAM Plc confirms talks with WH Ireland on possible offer

TEAM Plc has confirmed it is in talks with WH Ireland about a potential offer for the company’s entire issued and to be issued share capital...

A distinct approach to scaling new battery technology

Ilika is turning heads with its selective partnerships and strategic IP model, quietly reshaping expectations for solid-state battery adoption...

B&M European Value Retail delivers revenue growth as turnaround plan progresses

B&M European Value Retail reported a 4% rise in Group revenue to £2.75bn for the 26 weeks to 27 September 2025, supported by new store openings..
Search

Funds

November 13, 2025

RYDER provides specialist engineering for subsea cables and pipelines

RYDER focuses on subsea cable and pipeline design where depth, route and burial precision determine long‑term performance...

Graphite remains essential as industry shifts

Graphite demand is rising steadily as it remains critical for batteries, steelmaking, and thermal systems...

TEAM Plc confirms talks with WH Ireland on possible offer

TEAM Plc has confirmed it is in talks with WH Ireland about a potential offer for the company’s entire issued and to be issued share capital...

A distinct approach to scaling new battery technology

Ilika is turning heads with its selective partnerships and strategic IP model, quietly reshaping expectations for solid-state battery adoption...

B&M European Value Retail delivers revenue growth as turnaround plan progresses

B&M European Value Retail reported a 4% rise in Group revenue to £2.75bn for the 26 weeks to 27 September 2025, supported by new store openings and stable UK like-for-like sales...
Search

Funds

November 13, 2025

FTSE 100

Funds